Related Experiment Video
Updated: May 7, 2026

A Modified Simple Method for Induction of Myocardial Infarction in Mice
Published on: December 3, 2021
To B or not to B--that is the question for myocardial infarction
1Center for Immunology & Inflammatory Diseases, Division of Rheumatology, Allergy & Immunology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Insights
Following myocardial infarction (MI), B cells release Ccl7, attracting inflammatory monocytes to the heart. Depleting B cells post-MI reduces heart damage and improves function, offering a novel therapeutic strategy.
Area of Science:
- Immunology
- Cardiology
- Cell Biology
Background:
- Myocardial infarction (MI) triggers inflammatory responses that exacerbate cardiac damage.
- The role of B cells and specific chemokines in post-MI inflammation is not fully understood.
Discussion:
- This study reveals that B cells, after MI, secrete the chemokine Ccl7.
- Ccl7 acts as a crucial mediator, mobilizing inflammatory monocytes from bone marrow to circulation.
- These monocytes are subsequently recruited to the injured myocardial tissue, contributing to inflammation.
Key Insights:
- B cell-derived Ccl7 is a key driver of inflammatory monocyte recruitment to the heart post-MI.
- Targeting B cells or Ccl7 presents a potential therapeutic avenue for limiting myocardial injury.
- B cell depletion post-MI demonstrates efficacy in reducing cardiac damage and enhancing heart function.
Outlook:
- Further research into B cell-specific pathways could uncover new therapeutic targets for acute MI.
- Investigating the precise mechanisms of monocyte recruitment and function in the infarcted heart is warranted.
- Clinical trials evaluating B cell-targeted therapies for acute myocardial infarction management are a future possibility.
Abstract:
After myocardial infarction (MI), circulating B cells produce the chemokine Ccl7, which mobilizes inflammatory monocytes from the bone marrow into the blood, after which they are then recruited to the injured heart, a new study shows. B cell depletion after MI limits myocardial injury and improves heart function, suggesting a new approach for the management of acute MI (pages 1273–1280).
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome III: Diagnostic Studies
Angina II: Classification
Myocarditis I: Introduction

